全文获取类型
收费全文 | 8310篇 |
免费 | 445篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 178篇 |
妇产科学 | 125篇 |
基础医学 | 1190篇 |
口腔科学 | 194篇 |
临床医学 | 615篇 |
内科学 | 2097篇 |
皮肤病学 | 215篇 |
神经病学 | 658篇 |
特种医学 | 228篇 |
外科学 | 1156篇 |
综合类 | 35篇 |
预防医学 | 304篇 |
眼科学 | 199篇 |
药学 | 708篇 |
中国医学 | 22篇 |
肿瘤学 | 823篇 |
出版年
2023年 | 50篇 |
2022年 | 105篇 |
2021年 | 175篇 |
2020年 | 97篇 |
2019年 | 147篇 |
2018年 | 181篇 |
2017年 | 155篇 |
2016年 | 195篇 |
2015年 | 194篇 |
2014年 | 243篇 |
2013年 | 326篇 |
2012年 | 502篇 |
2011年 | 553篇 |
2010年 | 295篇 |
2009年 | 266篇 |
2008年 | 473篇 |
2007年 | 464篇 |
2006年 | 494篇 |
2005年 | 490篇 |
2004年 | 472篇 |
2003年 | 449篇 |
2002年 | 445篇 |
2001年 | 210篇 |
2000年 | 199篇 |
1999年 | 179篇 |
1998年 | 79篇 |
1997年 | 72篇 |
1996年 | 69篇 |
1995年 | 56篇 |
1994年 | 54篇 |
1993年 | 50篇 |
1992年 | 95篇 |
1991年 | 104篇 |
1990年 | 105篇 |
1989年 | 91篇 |
1988年 | 101篇 |
1987年 | 74篇 |
1986年 | 77篇 |
1985年 | 51篇 |
1984年 | 49篇 |
1983年 | 39篇 |
1982年 | 19篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1979年 | 21篇 |
1978年 | 18篇 |
1974年 | 18篇 |
1973年 | 14篇 |
1972年 | 25篇 |
1969年 | 19篇 |
排序方式: 共有8791条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
Makito Hirano Hirohide Asai Takao Kiriyama Yoshiko Furiya Takaaki Iwamoto Tomohisa Nishiwaki Aya Yamamoto Toshio Mori Satoshi Ueno 《Neuroscience letters》2007
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia (EAOH)/ataxia with oculomotor apraxia type 1 (AOA1) is caused by mutations in the gene encoding aprataxin (APTX). Although several in vitro findings proposed that impaired enzymatic activities of APTX are responsible for EAOH/AOA1, potential instability of mutant proteins has also been suggested as the pathogenesis based on in vivo finding that mutant proteins are almost undetectable in EAOH/AOA1 tissues or cells. The present study aimed to experimentally prove instability of mutant proteins in neuronal cells, the cell type preferentially affected by this disease. Results of pulse-chase experiments demonstrated that all of the disease-associated mutants had extremely shorter half-lives than the WT. We further found that mutants were targeted for rapid proteasome-mediated degradation. These results help establish pathogenic and physiological protein characteristics of APTX in neuronal cells. 相似文献
45.
46.
Yoshida T Iwamoto T Adachi K Yokota T Miyake Y Hamaguchi M 《International journal of molecular medicine》2005,15(2):269-275
M1 mouse myeloid leukemia cells exhibit growth arrest and differentiation to monocytes/macrophages in response to leukemia inhibitory factor (LIF) stimulation. Although recent studies have demonstrated that STAT3 plays a central role in this process, it is unknown whether STAT3 activation alone is sufficient. To address this issue, we have established M1/STAT3ER cells, where STAT3 is selectively activated by 4-hydroxytamoxifen (4HT). 4HT stimulation did not have any effect on growth and morphology of M1/ STAT3ER cells, and did not induce the down-regulation of mRNA of c-myc and c-myb, which is necessary for M1 cell differentiation. On the other hand, mRNA of jun-B, IRF1 and p19 was increased by 4HT. DNA precipitation assay indicated that both stimulation of LIF and 4HT similarly activated STAT3ER. Introduction of a constitutive active MAP kinase kinase (MEK1) into M1/STAT3ER cells did not induce differentiation either. Together, our present data suggest that signaling other than the activation of STAT3 and MEK1 may be necessary for M1 cell-growth arrest and differentiation, while a set of early genes of LIF are induced by only STAT3 activation. 相似文献
47.
We here report a molecular basis for downregulation of interferon (IFN)-beta production by V and C proteins of Sendai virus (SeV). The infection of HeLa cells with SeV poorly induced IFN-beta even if the expression of C/C' was disrupted. In contrast, when the expression of C/C'/Y1/Y2 or V/W was disrupted, SeV infection strongly induced IFN-beta production and significantly activated the interferon regulatory factor (IRF)-3 pathway. The independent expression of C or V inhibited the double-stranded (ds) RNA- or Newcastle disease virus (NDV)-induced activation of IRF-3 and NF-kappa B, as well as the IFN-beta promoter. This inhibitory effect was also observed when Y1, Y2, or a C-terminal half fragment (aa 85-204) of C was independently expressed. Phosphorylation and homodimer formation of IRF-3 were suppressed not only in cells infected with SeV capable of expressing both C/C'/Y1/Y2 (or Y1/Y2) and V/W, but also in HeLa cells constitutively expressing Y1. These results suggest that C, Y1, Y2, and V block signaling pathways leading to IRF-3 activation to downregulate IFN-beta production. 相似文献
48.
Pneumocystis carinii carriage in immunocompromised patients with and without human immunodeficiency virus infection 总被引:3,自引:0,他引:3
Takahashi T Goto M Endo T Nakamura T Yusa N Sato N Iwamoto A 《Journal of medical microbiology》2002,51(7):611-614
Eighty-one bronchoalveolar lavage (BAL) specimens obtained from 26 HIV-infected, 45 non-HIV immunosuppressed and 10 immunocompetent patients with primary pulmonary diseases were analysed for the presence of Pneumocystis carinii by staining and by P. carinii 5S rDNA determined by PCR. P. carinii was observed by staining of BAL specimens from HIV-infected patients significantly more frequently than those from immunocompromised hosts without HIV infection (57.7% versus 20.0%, respectively). P. carinii 5S rDNA was detected by PCR assay in seven (26.9%) HIV-infected individuals, which was significantly more frequent than for four (8.9%) immunosuppressed patients without HIV infection, for whom staining was negative. None of these patients developed P. carinii pneumonia (PCP) within the follow-up period. BAL specimens from 10 immunocompetent patients with pulmonary disorders were negative for PCP by both staining and PCR assay. 相似文献
49.
Miura T Goto M Hosoya N Odawara T Kitamura Y Nakamura T Iwamoto A 《Journal of medical virology》2003,70(4):497-505
Mitochondrial DNA (mtDNA) of peripheral blood mononuclear cells (PBMCs) collected from Human immunodeficiency virus 1 (HIV-1)-infected patients and healthy controls were measured longitudinally using real-time polymerase chain reaction to evaluate the effects of antiretroviral agents on mtDNA synthesis in vivo and to assess the value of monitoring mtDNA in PBMCs to predict adverse events amongst these patients. MtDNA levels in PBMCs were significantly decreased in treatment-naive HIV-1-infected patients compared with healthy people. MtDNA levels were not only significantly correlated with CD4(+) T-cell count, but also inversely correlated with HIV-1 viral load. MtDNA levels in untreated patients and healthy controls were stable during the period of observation. On the other hand, amongst patients treated with regimens containing AZT/3TC or d4T/3TC, mtDNA increased during treatment and recovered to levels comparable to healthy controls. In contrast, mtDNA decreased immediately after the initiation of an AZT/ddC-containing regimen. We did not find a correlation between mtDNA levels and changes in clinical parameters. There was no significant difference in mtDNA levels between patients with and those without lipoatrophy. Furthermore, there was no obvious difference in mtDNA levels amongst those patients exhibiting signs and symptoms of peripheral neuropathy. In conclusion, the decrease in mtDNA levels in PBMCs amongst HIV-1-infected patients and its amelioration by antiretroviral therapy may suggest the influence of direct effects on mitochondria or mtDNA by HIV-1 infection. Further investigations are needed to elucidate the mechanisms contributing to decreased mtDNA and the value of mtDNA measurement in the care of HIV-1-infected individuals. 相似文献